Managing Nausea and Dehydration on GLP-1s: Hydration Support for Common Side Effects

Updated: September 24, 2026

Written or co-written by Taylor Graber, MD
Initial medical review: January 12, 2026

Nausea, vomiting or reduced fluid intake while taking a GLP-1 medication warrants discussion with the prescribing clinician. Hydration can address fluid loss, but it does not identify the cause of symptoms or replace review of the medication and treatment plan. Persistent or severe symptoms should not be managed by booking a routine wellness infusion alone.

Medication Side Effects and Fluid Loss

Products have different indications, warnings and instructions. As one specific example, the FDA prescribing information for Ozempic (semaglutide) (readable manufacturer safety information) lists nausea, vomiting, diarrhea, abdominal pain and constipation among common adverse reactions. It also warns that gastrointestinal symptoms can lead to dehydration and kidney problems. These product-specific instructions should not be treated as the label for every GLP-1 or related medication.

Tell the prescribing clinician which medicine and dose you take, when symptoms started, whether the dose recently changed, and whether you can keep fluids down. Follow the instructions for your own prescription and obtain advice about any dose adjustment.

Oral Hydration and Clinical Assessment

MedlinePlus dehydration guidance explains that mild dehydration may be managed with oral fluids, while severe cases may require hospital treatment and IV fluids. If you can drink, small sips may be easier to tolerate. Ask your clinician how much fluid you should take; needs vary by person and medical condition.

A clinician may assess your symptoms, vital signs, kidney function and electrolyte levels before choosing treatment. An inability to keep fluids down or continuing vomiting needs prompt medical advice rather than an assumption that a standard infusion is appropriate.

When to Seek Urgent Care

For people using Ozempic, its Medication Guide directs contacting the healthcare provider right away for nausea, vomiting or diarrhea that does not go away. For severe abdominal pain that persists, with or without vomiting, it directs stopping Ozempic and calling the provider right away because pancreatitis may be involved. Consult your own medication's instructions; these are not directions to change every GLP-1 prescription.

Get medical help immediately for confusion, fainting, no urination, rapid breathing or other signs of severe dehydration. For chest pain or breathing problems, call 911 or the local emergency number. Do not wait for a routine IV appointment. General IV safety guidance also describes emergency warning signs.

What IV Hydration Can and Cannot Do

IV fluids bypass the digestive tract. Whether they are appropriate, and the amount and composition required, depend on clinical assessment. Fluid replacement does not establish that a vitamin blend treats medication side effects, improves energy or recovery, or produces immediate relief. The sources cited here do not establish those benefits for ASAP's GLP-1 Booster formula.

Discuss alternatives, fluid requirements, medicines and medical history with the treating clinician. Severe symptoms or suspected medication complications may require care beyond a routine infusion service. Browse our IV therapy menu only after determining the appropriate care setting.

ASAP GLP-1 Booster IV

GLP-1 Booster IV ($205) includes:

  • 1000 mL fluids

  • Vitamin C

  • Zinc

  • Magnesium

  • B1, B2, B3, B5, B6, B12

  • Zofran (anti-nausea medication)

This is the listed service composition, not a guarantee of suitability or symptom relief. The treating clinician should determine which fluids, ingredients and medications are appropriate. The nutrients' normal roles in the body do not establish benefit for medication side effects.

Discussing Ondansetron and Infusion Risks

Ondansetron injection information describes precautions involving heart rhythm disorders, low potassium or magnesium, other medicines and allergies. Discuss these with the treating clinician before receiving it. Its use for GLP-1-associated symptoms requires individual clinical judgment; the cited information does not establish automatic eligibility for this formula.

IV treatment and medications can cause adverse reactions. Tell the clinician immediately about concerning symptoms during an infusion; seek emergency help for chest pain or breathing problems. General source guidance is not a description of ASAP IVs' specific monitoring or emergency protocol.

Discuss Care Before Booking

If your prescribing clinician has assessed your symptoms and outpatient infusion is appropriate, discuss a GLP-1 Booster IV appointment. Results and timing vary. Persistent vomiting, severe abdominal pain or emergency warning signs require medical assessment rather than this booking link.

Taylor Graber